The DOI matches its Crossref record; 57 of the 57 references it cites were found in a registry or an index.
Reductions in circulating endocannabinoid levels in individuals with post-traumatic stress disorder following exposure to the world trade center attacks
Open accessAbstract
Endocannabinoid (eCB) signaling has been identified as a modulator of adaptation to stress, and is integral to basal and stress-induced glucocorticoid regulation. Furthermore, interactions between eCBs and glucocorticoids have been shown to be necessary for the regulation of emotional memories, suggesting that eCB function may relate to the development of post-traumatic stress disorder (PTSD). To examine this, plasma eCBs were measured in a sample (n=46) drawn from a population-based cohort selected for physical proximity to the World Trade Center (WTC) at the time of the 9/11 attacks. Participants received a structured diagnostic interview and were grouped according to whether they met diagnostic criteria for PTSD (no PTSD, n=22; lifetime diagnosis of PTSD=24). eCB content (2-arachidonoylglycerol (2-AG) and anandamide (AEA)) and cortisol were measured from 8 a.m. plasma samples. Circulating 2-AG content was significantly reduced among individuals meeting diagnostic criteria for PTSD. The effect of reduced 2-AG content in PTSD remained significant after controlling for the stress of exposure to the WTC collapse, gender, depression and alcohol abuse. There were no significant group differences for AEA or cortisol levels; however, across the whole sample AEA levels positively correlated with circulating cortisol, and AEA levels exhibited a negative relationship with the degree of intrusive symptoms within the PTSD sample. This report shows that PTSD is associated with a reduction in circulating levels of the eCB 2-AG. Given the role of 2-AG in the regulation of the stress response, these data support the hypothesis that deficient eCB signaling may be a component of the glucocorticoid dysregulation associated with PTSD. The negative association between AEA levels and intrusive symptoms is consistent with animal data indicating that reductions in AEA promote retention of aversive emotional memories. Future work will aim to replicate these findings and extend their relevance to clinical pathophysiology, as well as to neuroendocrine and molecular markers of PTSD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“AEA levels have been shown to be reduced in PTSD patients (Hill et al., 2013;Neumeister et al., 2013) and depressed patients with high anxiety scores (Hill, Miller, Carrier, Gorzalka, & Hillard, 2009;Hill, Miller, Ho, Gorzalka, & Hillard, 2008).”
From Novel pharmacological targets in drug development for the treatment of anxiety and anxiety-related disorders (2019) · cites this paper as Hill et al., 2013
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The development of a Clinician-Administered PTSD Scale
Blake, D. D., Weathers, F. W., Nagy, L. M., Kaloupek, D. G., Gusman, F. D., Charney, D. S., & Keane, T. M. (1995) · Journal of Traumatic Stress · doi:10.1002/jts.2490080106 · Cited by 5,024
Reliability and validity of a brief instrument for assessing post-traumatic stress disorder
Foa, E. B., Riggs, D. S., Dancu, C. V., & Rothbaum, B. O. (1993) · Journal of Traumatic Stress · doi:10.1002/jts.2490060405 · Cited by 2,537
The endogenous cannabinoid system controls extinction of aversive memories
Marsicano, G., Wotjak, C. T., Azad, S. C., Bisogno, T., Rammes, G., Cascio, M. G., Hermann, H., Tang, J., Hofmann, C., Zieglgänsberger, W., et al. (2002) · Nature · doi:10.1038/nature00839 · Cited by 1,728
Di, S., Malcher‐Lopes, R., Halmos, K. C., & Tasker, J. G. (2003) · Journal of Neuroscience · doi:10.1523/jneurosci.23-12-04850.2003 · Cited by 820
Breslau, N., Davis, G. C., Peterson, E. L., & Schultz, L. R. (2000) · Biological Psychiatry · doi:10.1016/s0006-3223(00)00933-1 · Cited by 582
Enzymatic pathways that regulate endocannabinoid signaling in the nervous system
Ahn, K., McKinney, M. K., & Cravatt, B. F. (2008) · Chemical Reviews · doi:10.1021/cr0782067 · Cited by 529
Patel, S., Roelke, C. T., Rademacher, D. J., Cullinan, W. E., & Hillard, C. J. (2004) · Endocrinology · doi:10.1210/en.2004-0638 · Cited by 475
Self-citationStructured Clinical Interview for DSM-IV (SCID)
Kübler, U. (2013) · Springer eBooks · doi:10.1007/978-1-4419-1005-9_66 · Cited by 445
Status of Glucocorticoid Alterations in Post‐traumatic Stress Disorder
Yehuda, R. (2009) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2009.04979.x · Cited by 409
Self-citationEnhancing Cannabinoid Neurotransmission Augments the Extinction of Conditioned Fear
Chhatwal, J. P., Davis, M., Maguschak, K. A., & Ressler, K. J. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300655 · Cited by 376
Cited by
Sorted by citations
Items 101–200 of 256
Korem, N., Lange, R., Hillard, C. J., & Akirav, I. (2017) · Neuroscience · doi:10.1016/j.neuroscience.2017.06.015 · Cited by 27
Self-citationOn making (and turning adaptive to) maladaptive aversive memories in laboratory rodents
Gazarini, L., Stern, C. A. J., & Bertoglio, L. J. (2023) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2023.105101 · Cited by 27
Zoladz, P. R., Kalchik, A. E., Hoffman, M. M., Aufdenkampe, R. L., Lyle, S. M., Peters, D. M., Brown, C. M., Cadle, C. E., Scharf, A. R., Dailey, A. M., et al. (2014) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2014.06.012 · Cited by 26
Ferrer, Á., Labad, J., Salvat‐Pujol, N., Monreal, J. A., Urretavizcaya, M., Crespo, J. M., Menchón, J. M., Palao, D. J., & Soria, V. (2020) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2020.109929 · Cited by 27
Pereira, S. R., Velasquez, J. T., Duggan, S., Ivanisevic, B., McKenna, J. P., McCreary, C., & Downer, E. J. (2020) · European Journal of Neuroscience · doi:10.1111/ejn.14712 · Cited by 25
Hahnefeld, L., Vogel, A., Gurke, R., Geißlinger, G., Schäfer, M. K. E., & Tegeder, I. (2022) · Biomedicines · doi:10.3390/biomedicines10040914 · Cited by 23
Medical cannabis for treatment-resistant combat PTSD
Nacasch, N., Avni, C., & Toren, P. (2023) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.1014630 · Cited by 23
Bennett, M. R., Arnold, J. C., Hatton, S. N., & Lagopoulos, J. (2016) · Behavioural Brain Research · doi:10.1016/j.bbr.2016.11.029 · Cited by 22
Kaczocha, M., Azim, S., Nicholson, J., Rebecchi, M. J., Lu, Y., Feng, T., Romeiser, J. L., Reinsel, R. A., Rizwan, S., Shodhan, S., et al. (2018) · BMC Anesthesiology · doi:10.1186/s12871-018-0489-5 · Cited by 23
Diacylglycerol lipase alpha in astrocytes is involved in maternal care and affective behaviors
Schüle, L., Glasmacher, S., Gertsch, J., Roggan, M. D., Transfeld, J. L., Bîndilă, L., Lutz, B., Kolbe, C., Bilkei‐Gorzó, A., Zimmer, A., et al. (2020) · Glia · doi:10.1002/glia.23903 · Cited by 25
Kang, M., Bohorquez‐Montoya, L., McAuliffe, T. L., Claesges, S. A., Blair, N.-O. P., Sauber, G., Reynolds, C. F., Hillard, C. J., & Goveas, J. S. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.783187 · Cited by 22
Self-citationGrimsey, N. L., Savinainen, J. R., Attili, B. N. N. R., & Ahamed, M. (2019) · Drug Discovery Today · doi:10.1016/j.drudis.2019.10.004 · Cited by 22
Exo- and Endo-cannabinoids in Depressive and Suicidal Behaviors
Thippaiah, S. M., Iyengar, S. S., & Vinod, K. Y. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.636228 · Cited by 21
Atsak, P., Morena, M., Schoenmaker, C., Tabak, E., Oomen, C. A., Jamil, S., Hill, M. N., & Roozendaal, B. (2018) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2018.02.021 · Cited by 22
Self-citationHarris, B. N., Hohman, Z. P., Campbell, C. M., King, K. S., & Tucker, C. A. (2019) · Neurobiology of Stress · doi:10.1016/j.ynstr.2019.100154 · Cited by 22
PTSD Symptom Clusters and Craving Differs by Primary Drug of Choice
Somohano, V. C., Rehder, K. L., Dingle, T., Shank, T. M., & Bowen, S. W. (2019) · Journal of Dual Diagnosis · doi:10.1080/15504263.2019.1637039 · Cited by 23
Use of cannabinoids for the treatment of patients with post-traumatic stress disorder
Forsythe, M. L., & Boileau, A. J. (2021) · Journal of Basic and Clinical Physiology and Pharmacology · doi:10.1515/jbcpp-2020-0279 · Cited by 20
Untapped endocannabinoid pharmacological targets: Pipe dream or pipeline?
Wilkerson, J. L., Bilbrey, J. A., Felix, J. S., Makriyannis, A., & McMahon, L. R. (2021) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2021.173192 · Cited by 20
Leen, N. A., de Weijer, A. D., van Rooij, S. J. H., Kennis, M., Baas, J. M. P., & Geuze, E. (2022) · Chronic Stress · doi:10.1177/24705470221107290 · Cited by 18
Fotio, Y., Tagne, A. M., Jung, K., & Piomelli, D. (2023) · Psychopharmacology · doi:10.1007/s00213-023-06358-y · Cited by 19
Genome-wide expression and response to exposure-based psychological therapy for anxiety disorders
Roberts, S., Wong, C. C. Y., Breen, G. D., Coleman, J. R. I., de Jong, S., Jöhren, P., Keers, R., Curtis, C. J. C., Lee, S. H., Margraf, J., et al. (2017) · Translational Psychiatry · doi:10.1038/tp.2017.177 · Cited by 22
Nicholson, J., Azim, S., Rebecchi, M. J., Galbavy, W., Feng, T., Reinsel, R. A., Rizwan, S., Fowler, C. J., Benveniste, H., & Kaczocha, M. (2015) · PLoS ONE · doi:10.1371/journal.pone.0123132 · Cited by 17
Potential Utility of Cannabidiol in Stress-Related Disorders
Lookfong, N. A., Raup‐Konsavage, W. M., & Silberman, Y. (2022) · Cannabis and Cannabinoid Research · doi:10.1089/can.2022.0130 · Cited by 18
Endocannabinoid-Epigenetic Cross-Talk: A Bridge toward Stress Coping
Rusconi, F., Rubino, T., & Battaglioli, E. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21176252 · Cited by 19
Barry, A., O’Halloran, K. D., McKenna, J. P., McCreary, C., Harhen, B., Kerr, D. M., Finn, D. P., & Downer, E. J. (2018) · Journal of Oral Pathology and Medicine · doi:10.1111/jop.12692 · Cited by 18
Kondev, V., Winters, N. D., & Patel, S. (2021) · International review of neurobiology · doi:10.1016/bs.irn.2020.09.007 · Cited by 21
Circulating endocannabinoid concentrations in grieving adults
Harfmann, E. J., McAuliffe, T. L., Larson, E. R., Claesges, S. A., Sauber, G., Hillard, C. J., & Goveas, J. S. (2020) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2020.104801 · Cited by 17
Self-citationStefano, V. D., Steardo, L., D’Angelo, M., Monaco, F., & Steardo, L. (2025) · Biomedicines · doi:10.3390/biomedicines13061271 · Cited by 20
A Clinician’s Guide to PTSD Biomarkers and Their Potential Future Use
Yang, S. M., Wynn, G. H., & Ursano, R. J. (2018) · FOCUS The Journal of Lifelong Learning in Psychiatry · doi:10.1176/appi.focus.20170045 · Cited by 16
Increased cortisol levels are associated with low treatment retention in crack cocaine users
Ligabue, K. P., Schuch, J. B., Scherer, J. N., Ornell, F. R., Roglio, V. S., de Assunção, V. A. F., Rebelatto, F. P., Hidalgo, M. P., Pechansky, F., Kessler, F. H. P., et al. (2019) · Addictive Behaviors · doi:10.1016/j.addbeh.2019.106260 · Cited by 17
In it together? The case for endocannabinoid–noradrenergic interactions in fear extinction
Warren, W. G., Papagianni, E. P., Stevenson, C. W., & Stubbendorff, C. (2021) · European Journal of Neuroscience · doi:10.1111/ejn.15200 · Cited by 18
Gazarini, L., Stern, C. A. J., Takahashi, R. N., & Bertoglio, L. J. (2021) · Neuroscience · doi:10.1016/j.neuroscience.2021.09.012 · Cited by 17
Marusak, H. A., Ely, S. L., Zundel, C. G., Gowatch, L. C., Shampine, M. M., Carpenter, C., Tamimi, R., Jaster, A. M., Shakir, T., May, L., et al. (2024) · Psychopharmacology · doi:10.1007/s00213-024-06717-3 · Cited by 17
Self-citationBlood endocannabinoid levels in patients with panic disorder
Petrowski, K., Kirschbaum, C., Gao, W., Hardt, J., & Conrad, R. (2020) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2020.104905 · Cited by 15
Kondev, V., Morgan, A., Najeed, M., Winters, N. D., Kingsley, P. J., Marnett, L. J., & Patel, S. (2022) · Biological Psychiatry · doi:10.1016/j.biopsych.2022.05.012 · Cited by 17
Endogenous cannabinoid levels and suicidality in combat veterans
Sher, L., Bierer, L. M., Flory, J. D., Hill, M. N., Makotkine, I., & Yehuda, R. (2019) · Psychiatry Research · doi:10.1016/j.psychres.2019.112495 · Cited by 17
Self-citationCannabis use in the United States and its impact on gastrointestinal health
Alshaarawy, O., Balasubramanian, G., & Venkatesan, T. (2023) · Nutrition in Clinical Practice · doi:10.1002/ncp.11111 · Cited by 16
O'Donohue, M. P., Hamzah, K. A., Nichols, D. S., & Ney, L. J. (2024) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2024.107007 · Cited by 15
Endocannabinoid Hydrolase Inhibitors: Potential Novel Anxiolytic Drugs
Zhao, H., Liu, Y., Cai, N., Liao, X., Tang, L., & Wang, Y. (2024) · Drug Design Development and Therapy · doi:10.2147/dddt.s462785 · Cited by 15
Fuentes, J. J., Mayans, J., Guarro, M., Canosa, I., Mestre-Pintó, J. I., Fonseca, F., & Torrens, M. (2024) · BMC Psychiatry · doi:10.1186/s12888-024-05986-8 · Cited by 14
Prefrontal correlates of fear generalization during endocannabinoid depletion
Rosas-Vidal, L. E., Naskar, S., Mayo, L. M., Perini, I., Masroor, R., Altemus, M., Ramos-Medina, L., Zaidi, S. D., Engelbrektsson, H., Jagasia, P., et al. (2025) · Journal of Clinical Investigation · doi:10.1172/jci179881 · Cited by 15
Endocannabinoid interactions in the regulation of acquisition of contextual conditioned fear
Balogh, Z., Szente, L., Bíró, L., Varga, Z. K., Haller, J., & Aliczki, M. (2018) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2018.11.007 · Cited by 16
Endocannabinoids and Precision Medicine for Mood Disorders and Suicide
Pinna, G. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.658433 · Cited by 13
Danan, D., Todder, D., Zohar, J., & Cohen, H. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22126416 · Cited by 13
Circulating endocannabinoids during hematopoietic stem cell transplantation: A pilot study
Knight, J. M., Szabó, A., Zhao, S., Lyness, J. M., Sahler, O. J. Z., Liesveld, J. L., Sander, T. L., Rizzo, J. D., Hillard, C. J., & Moynihan, J. A. (2015) · Neurobiology of Stress · doi:10.1016/j.ynstr.2015.05.001 · Cited by 13
Self-citationThe endocannabinoid system in social anxiety disorder: from pathophysiology to novel therapeutics
Ahmed, M., Boileau, I., Le Foll, B., Carvalho, A. F., & Kloiber, S. (2022) · Brazilian Journal of Psychiatry · doi:10.1590/1516-4446-2021-1926 · Cited by 11
Cannabidiol and the corticoraphe circuit in post-traumatic stress disorder
Alexander, C., & Vasefi, M. (2021) · IBRO Neuroscience Reports · doi:10.1016/j.ibneur.2021.08.001 · Cited by 12
Ferger, M. D., Sigrist, C., Brodesser, S., Kaess, M., & Koenig, J. (2024) · Translational Psychiatry · doi:10.1038/s41398-024-03205-2 · Cited by 12
Lindgren, L., Gouveia-Figueira, S. C., Nording, M. L., & Fowler, C. J. (2015) · BMC Research Notes · doi:10.1186/s13104-015-1450-z · Cited by 11
Petrowski, K., & Conrad, R. (2019) · Psychopathology · doi:10.1159/000496559 · Cited by 11
Bergunde, L., Karl, M., Schälicke, S., Weise, V., Mack, J. T., von Soest, T., Gao, W., Weidner, K., Garthus‐Niegel, S., & Steudte‐Schmiedgen, S. (2023) · Translational Psychiatry · doi:10.1038/s41398-023-02610-3 · Cited by 9
Circuit mechanisms governing endocannabinoid modulation of affective behaviour and stress adaptation
Loomba, N., & Patel, S. (2025) · Nature reviews. Neuroscience · doi:10.1038/s41583-025-00961-y · Cited by 11
Ney, L. J., Akóṣílè, W., Davey, C. G., Pitcher, L., Felmingham, K. L., Mayo, L. M., Hill, M. N., & Strodl, E. S. (2023) · Expert Review of Clinical Pharmacology · doi:10.1080/17512433.2023.2276309 · Cited by 9
Self-citationFischer, C., Thomas, D., Gurke, R., & Tegeder, I. (2024) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-024-03012-0 · Cited by 9
Weisser, S., Mueller, M., Rauh, J., Esser, R. W., Fuß, J., Lutz, B., & Haaker, J. (2022) · Neuropsychopharmacology · doi:10.1038/s41386-022-01320-6 · Cited by 9
Redlich, C., Dlugos, A. M., Hill, M. N., Patel, S., Korn, D., Enneking, V., Foerster, K., Arolt, V., Domschke, K., Dannlowski, U., et al. (2020) · Neuropsychopharmacology · doi:10.1038/s41386-020-00870-x · Cited by 9
Self-citationUpdates on Pharmacological Treatment of Post-Traumatic Stress Disorder
Koirala, R., Søegaard, E. G. I., & Thapa, S. B. (2017) · Journal of Nepal Medical Association · doi:10.31729/jnma.3108 · Cited by 9
Patel, S., Shonesy, B. C., Bluett, R. J., Winder, D. G., & Colbran, R. J. (2015) · Biological Psychiatry · doi:10.1016/j.biopsych.2015.04.028 · Cited by 9
Rajasekera, T. A., Joseph, A., Pan, H., Dreyfuss, J. M., Fida, D., Wilson, J. C., Behee, M., Fichorova, R. N., Cinar, R., & Spagnolo, P. A. (2025) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2025.111501 · Cited by 9
Mechanism of action of sedatives, hypnotics, and antianxiety drugs
Nisar, M. A., & Saleem, M. Z. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-99855-0.00007-5 · Cited by 7
Lemieux, A. M., Nakajima, M., Saif-Ali, R., Al‐Habori, M., Dokam, A., & Al’Absi, M. (2018) · Addictive Behaviors · doi:10.1016/j.addbeh.2018.02.033 · Cited by 8
Piggott, V. M., Lloyd, S. C., Matchynski, J. I., Perrine, S. A., & Conti, A. C. (2021) · Molecules · doi:10.3390/molecules26072086 · Cited by 8
Kwee, C., van der Flier, F. E., Duits, P., van Balkom, A. J. L. M., Cath, D. C., & Baas, J. M. P. (2023) · Psychopharmacology · doi:10.1007/s00213-023-06512-6 · Cited by 7
The endocannabinoid system and posttraumatic stress disorder (PTSD): A new narrative
Ney, L. J., Crombie, K. M., & Mayo, L. M. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-90877-1.00013-9 · Cited by 7
Portugalov, A., & Akirav, I. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22020730 · Cited by 8
A precision medicine approach to pharmacological adjuncts to extinction: A call to broaden research
King, G., Baker, K. D., Bisby, M. A., Chan, D., Cowan, C. S. M., Stylianakis, A. A., Zimmermann, K. S., & Richardson, R. (2019) · Psychopharmacology · doi:10.1007/s00213-018-4999-0 · Cited by 6
Marusak, H. A., Zundel, C. G., Shakir, T., Ely, S. L., Carpenter, C., Shampine, M. M., Tamimi, R., Matsko, M., Rogers, S., Losiowski, J., et al. (2025) · Neuropsychopharmacology · doi:10.1038/s41386-025-02155-7 · Cited by 6
Self-citationSzente, L., Balla, G. Y., Varga, Z. K., Tóth, B., Bíró, L., Balogh, Z., Hill, M. N., Tóth, M., Mikics, É., & Aliczki, M. (2024) · Neurobiology of Stress · doi:10.1016/j.ynstr.2024.100662 · Cited by 6
Self-citationWalther, A., Eggenberger, L., Debelak, R., Kirschbaum, C., Häberling, I. S., Osuna, E., Strumberger, M. A., Walitza, S., Baumgartner, J., Herter‐Aeberli, I., et al. (2025) · Translational Psychiatry · doi:10.1038/s41398-025-03401-8 · Cited by 8
Understanding the Role of Endocannabinoids in Posttraumatic Stress Disorder
Ney, L. J. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26125527 · Cited by 6
Bergunde, L., Steudte‐Schmiedgen, S., Karl, M., Jaramillo, I., Gao, W., von Soest, T., & Garthus‐Niegel, S. (2024) · Scientific Reports · doi:10.1038/s41598-024-59818-6 · Cited by 5
Ruat, J., dos Santos, A. H., Heinz, D. E., Nemcova, P., Stoffel, R., Deussing, J. M., Chen, A., & Wotjak, C. T. (2021) · Genes Brain & Behavior · doi:10.1111/gbb.12775 · Cited by 8
Endocannabinoids, “New-Old” Mediators of Stress Homeostasis
Hauer, D., Tóth, R., & Schelling, G. (2019) · Springer eBooks · doi:10.1007/978-3-030-16996-1_10 · Cited by 5
PET Imaging of the Endocannabinoid System
Terry, G. E., Raymont, V., & Horti, A. G. (2020) · Springer eBooks · doi:10.1007/978-3-030-53176-8_12 · Cited by 5
Woodward, T. J., Dimén, D., Sizemore, E. F., Stockman, S., Kazi, F., Luquet, S. H., Mackie, K., Katona, I., & Hohmann, A. G. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.09.10.612324 · Cited by 5
Pharmacological diacylglycerol lipase inhibition impairs contextual fear extinction in mice
Ramos-Medina, L., Rosas-Vidal, L. E., & Patel, S. (2024) · Psychopharmacology · doi:10.1007/s00213-023-06523-3 · Cited by 4
Endocannabinoid system in trauma and psychosis: distant guardian of mental stability
Bielawski, T., Albrechet‐Souza, L., & Frydecka, D. (2021) · Reviews in the Neurosciences · doi:10.1515/revneuro-2020-0102 · Cited by 4
Hahnefeld, L., Hackel, J., Trautmann, S., Angioni, C., Schreiber, Y., Gurke, R., Thomas, D., Wicker, S., Geißlinger, G., & Tegeder, I. (2024) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00630.2024 · Cited by 4
Doucette, M. L., Hemraj, D., Macfarlan, D. L., Chin, J., & Fisher, E. (2025) · Clinical Drug Investigation · doi:10.1007/s40261-025-01424-z · Cited by 3
Song, C., Wanjun, L. I., Xiaohui, M. E. N. G., Yilun, X., Fu, Z., & Jianping, W. A. N. G. (2018) · Acta Psychologica Sinica · doi:10.3724/sp.j.1041.2018.01400 · Cited by 4
Hitzler, M., Matits, L., Gumpp, A. M., Bach, A. M., Ziegenhain, U., Gao, W., Kolassa, I., & Behnke, A. (2023) · Psychological Medicine · doi:10.1017/s0033291723001204 · Cited by 5
Vega-Torres, J. D., Kalyan-Masih, P., Argueta, D. A., DiPatrizio, N. V., & Figueroa, J. D. (2019) · Matters Select · doi:10.19185/matters.201906000003 · Cited by 4
Jaster, A. M., Ely, S. L., Zundel, C. G., Gowatch, L. C., Shampine, M. M., Carpenter, C., O’Mara, E., Bhogal, A., Tamimi, R., Lewis, C., et al. (2025) · Psychopharmacology · doi:10.1007/s00213-025-06831-w · Cited by 3
Endocannabinoids, cortisol, and development of post-traumatic psychopathological trajectories
Jayan, D., Timmer‐Murillo, S. C., Fitzgerald, J. M., Hillard, C. J., & deRoon‐Cassini, T. A. (2023) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2023.11.002 · Cited by 3
Self-citationAmygdala Cannabinoid 1 Receptor, Pain Response, and Emotional Numbing in Trauma-Exposed Individuals
Korem, N., Hillmer, A. T., D’Souza, D. C., Nia, A. B., Levy, I., Pietrzak, R. H., & Harpaz‐Rotem, I. (2024) · JAMA Network Open · doi:10.1001/jamanetworkopen.2024.32387 · Cited by 3
Dargahi, M., Karimi, G., Etemad, L., Alavi, M. S., & Roohbakhsh, A. (2023) · Learning and Motivation · doi:10.1016/j.lmot.2023.101872 · Cited by 3
Bottiroli, S., Greco, R., Franco, V., Zanaboni, A., Palmisani, M., Vaghi, G., Sances, G., Icco, R. D., & Tassorelli, C. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25031893 · Cited by 3
Ney, L. J., Matthews, A. J., Bruno, R., & Felmingham, K. L. (2019) · European Journal of Neuroscience · doi:10.1111/ejn.14371 · Cited by 3
Doucette, M. L., Macfarlan, D. L., Kasabuski, M., Chin, J., & Fisher, E. (2024) · medRxiv · doi:10.1101/2024.11.25.24317892 · Cited by 3
Eales, K., Lipp, O. V., Anderson, J., Jarvis, M. A., & Ney, L. J. (2025) · Behaviour Research and Therapy · doi:10.1016/j.brat.2025.104828 · Cited by 4
Kamuhanda, J. K. (2023) · International Journal of Advanced Scientific Research and Management · doi:10.36282/ijasrm/8.12.2023.1920 · Cited by 1
Pereira, C. F., Boileau, I., & Kloiber, S. M. (2025) · Discover Mental Health · doi:10.1007/s44192-025-00155-z · Cited by 3
Korem, N., Nia, A. B., Hillmer, A. T., D’Souza, D. C., Nabulsi, N., Ropchan, J. R., Huang, Y. H., Cosgrove, K., Levy, I., Pietrzak, R. H., et al. (2025) · Translational Psychiatry · doi:10.1038/s41398-025-03519-9 · Cited by 5
Chu, L., Wang, L., Wu, Y., Yang, H., Wang, W., Lu, Q., & Deng, H. (2022) · Actas Dermo-Sifiliográficas · doi:10.1016/j.ad.2022.02.016 · Cited by 2
RetractedEndocannabinoids, Stress, and Negative Affect
Berger, A. L., Henricks, A. M., Hill, M. N., & McLaughlin, R. J. (2017) · Springer eBooks · doi:10.1007/978-3-319-57371-7_3 · Cited by 2
Self-citationTranslational Impacts of World Trade Center Health Program Research: A Mixed Methods Study
Concannon, T. W., Faherty, L. J., Madrigano, J., Mann, S., Chari, R., Siddiqi, S. M., Lee, J., & Hiatt, L. (2021) · Rand health quarterly · doi:10.7249/rhq-09-03-08 · Cited by 2
Herrera-Imbroda, J., Flores-López, M., Requena-Ocaña, N., Araos, P. F., Ropero, J., García‐Marchena, N., Bordallo-Aragón, A., Suárez, J., Pavón, F. J., Serrano, A., et al. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24119371 · Cited by 2
Onu, I., Buculei, I., Ionescu, C. G., Stanca, D. N., Voicu, B., & Iordan, D. A. (2023) · BRAIN BROAD RESEARCH IN ARTIFICIAL INTELLIGENCE AND NEUROSCIENCE · doi:10.18662/brain/14.2/456 · Cited by 2
Gaudette, E. V., Watling, S. E., Warsh, J. J., McCluskey, T., Tong, J., Houle, S., Rusjan, P., Rhind, S. G., Bazinet, R. P., Tyndale, R. F., et al. (2020) · Biological Psychiatry · doi:10.1016/j.biopsych.2020.02.729 · Cited by 2
Self-citationCannabinoid-Based Medicine: Pharmacology and Drug Interactions
Davis, M. P. (2022) · Springer eBooks · doi:10.1007/978-3-030-89918-9_2 · Cited by 2
Metadata
- Authors
- Hill, M. N., Bierer, L. M., Makotkine, I., Golier, J. A., Galea, S., McEwen, B. S., Hillard, C. J., & Yehuda, R.
- Affiliations
- University of Calgary (CA)
- James J. Peters VA Medical Center (US)
- Columbia University (US)
- Rockefeller University (US)
- Medical College of Wisconsin (US)
- Corresponding author
- Hill, Matthew N.
- Venue
- Psychoneuroendocrinology
- Publisher
- Elsevier BV
- Published
- 2013-12
- Volume
- 38
- Issue
- 12
- Pages
- 2952-2961
- ISSN
- 0306-4530 (ISSN-L)
- PMC
- PMC3870889
- OpenAlex
- W2024564598
- Cited by
- 256
- References
- 56
- Citations by year
- 2026: 8 · 2025: 27 · 2024: 24 · 2023: 22 · 2022: 15 · 2021: 28 · 2020: 24 · 2019: 22 · 2018: 28 · 2017: 16 · 2016: 10 · 2015: 19 · 2014: 10 · 2013: 2
- FWCI
- 10.03
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Psychoneuroendocrinology (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- Canadian Institutes of Health Research
- National Institute of Mental Health (MH-41256, R37MH041256, R01MH041256, R56MH077321)
- National Institute on Drug Abuse (R01DA026996, DA026996)
- National Center for Research Resources (5 M01RR00071, M01RR000071)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Cannabis and Cannabinoid Research
- Social Sciences › Psychology › Clinical Psychology › Posttraumatic Stress Disorder Research
- Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
- Keywords
- post-traumatic stress disorder, endocannabinoids, 2-arachidonoylglycerol, anandamide, cortisol, September 11 attacks, World Trade Center, intrusion symptoms, emotional memory, stress response, plasma biomarkers
- MeSH terms
- Aged, Alcoholism, Amides, Arachidonic Acids, Ethanolamines, Ethnicity, Female, Glycerides, Humans, Hydrocortisone, Male, Middle Aged, Neuropsychological Tests, Oleic Acids, Palmitic Acids, Psychiatric Status Rating Scales, Sex Characteristics, Stress Disorders, Post-Traumatic, Terrorism, Polyunsaturated Alkamides, Endocannabinoids
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review